Publications

Found 39 results
Filters: Author is Kretzler, Matthias  [Clear All Filters]
2017
Lee HWon, Khan SQ, Khaliqdina S, Altintas MM, Grahammer F, Zhao JL, Koh KHye, Tardi NJ, Faridi MHafeez, Geraghty T et al..  2017.  Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.. J Biol Chem. 292(2):732-747.
Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R et al..  2017.  APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.. Nephrol Dial Transplant. 32(6):983-990.
Hinder LM, Park M, Rumora AE, Hur J, Eichinger F, Pennathur S, Kretzler M, Brosius FC, Feldman EL.  2017.  Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease.. J Cell Mol Med. 21(9):2140-2152.
Crawford BD, Gillies CE, Robertson CC, Kretzler M, Otto EA, Vega-Warner V, Sampson MG.  2017.  Erratum to: Evaluating Mendelian nephrotic syndrome genes for evidence for risk alleles or oligogenicity that explain heritability.. Pediatr Nephrol. 32(7):1285.
Crawford BD, Gillies CE, Robertson CC, Kretzler M, Otto E, Vega-Wagner V, Sampson MG.  2017.  Evaluating Mendelian nephrotic syndrome genes for evidence for risk alleles or oligogenicity that explain heritability.. Pediatr Nephrol. 32(3):467-476.
Nishizono R, Kikuchi M, Wang SQ, Chowdhury M, Nair V, Hartman J, Fukuda A, Wickman L, Hodgin JB, Bitzer M et al..  2017.  FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.. J Am Soc Nephrol. 28(10):2931-2945.
Levin A, Tonelli M, Bonventre J, Coresh J, Donner J-A, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M et al..  2017.  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.. Lancet. 390(10105):1888-1917.
Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZYousuf, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I et al..  2017.  Growth Differentiation Factor-15 and Risk of CKD Progression.. J Am Soc Nephrol. 28(7):2233-2240.
Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien H-P et al..  2017.  Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.. Nephrol Dial Transplant.
Afshinnia F, Zeng L, Byun J, Gadegbeku CA, Magnone MChiara, Whatling C, Valastro B, Kretzler M, Pennathur S.  2017.  Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.. Am J Nephrol. 46(1):73-81.
Skorecki KL, Lee JH, Langefeld CD, Rosset S, Tzur S, Wasser WG, Shemer R, Hawkins GA, Divers J, Parekh RS et al..  2017.  A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.. Nephrol Dial Transplant.
Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG, Werner T, Kretzler M, Brosius FC.  2017.  Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.. Kidney Int. 92(4):909-921.
Lindenmeyer MT, Kretzler M.  2017.  Renal biopsy-driven molecular target identification in glomerular disease.. Pflugers Arch. 469(7-8):1021-1028.
Berthier CC, Kretzler M, Davidson A.  2017.  A systems approach to renal inflammation in SLE.. Clin Immunol. 185:109-118.
Shved N, Warsow G, Eichinger F, Hoogewijs D, Brandt S, Wild P, Kretzler M, Cohen CD, Lindenmeyer MT.  2017.  Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts.. Sci Rep. 7(1):8576.
Liu P, Lassén E, Nair V, Berthier CC, Suguro M, Sihlbom C, Kretzler M, Betsholtz C, Haraldsson B, Ju W et al..  2017.  Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.. J Am Soc Nephrol. 28(10):2961-2972.
2016
Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K et al..  2016.  Complete Remission in the Nephrotic Syndrome Study Network.. Clin J Am Soc Nephrol. 11(1):81-9.
Mariani LH, Pendergraft WF, Kretzler M.  2016.  Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.. Clin J Am Soc Nephrol. 11(11):2054-2060.
Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V et al..  2016.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.. J Am Soc Nephrol. 27(3):814-23.
Brosius FC, Tuttle KR, Kretzler M.  2016.  JAK inhibition in the treatment of diabetic kidney disease.. Diabetologia. 59(8):1624-7.
Pedigo CE, Ducasa GMichelle, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, Molina-David J, Ge M, Lassenius MI, Forsblom C et al..  2016.  Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.. J Clin Invest. 126(9):3336-50.
McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, Kang HMin, Fuchsberger C, Danecek P, Sharp K et al..  2016.  A reference panel of 64,976 haplotypes for genotype imputation.. Nat Genet. 48(10):1279-83.
Yu H, Artomov M, Brähler S, M Stander C, Shamsan G, Sampson MG, J White M, Kretzler M, Miner JH, Jain S et al..  2016.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.. J Clin Invest. 126(4):1603.
Yu H, Artomov M, Brähler S, M Stander C, Shamsan G, Sampson MG, J White M, Kretzler M, Miner JH, Jain S et al..  2016.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.. J Clin Invest. 126(3):1067-78.
Saito R, Rocanin-Arjo A, You Y-H, Darshi M, Van Espen B, Miyamoto S, Pham J, Pu M, Romoli S, Natarajan L et al..  2016.  Systems biology analysis reveals role of MDM2 in diabetic nephropathy.. JCI Insight. 1(17):e87877.

Pages